Business · 18/11/2019Updated: 10/17/2026 · 1 min read
Pan American Laboratories, LLC, et al. Seek FDA Hearing on Withdrawal of Four New Drug Applications
Summary
The FDA is proposing to withdraw approval of four new drug applications from multiple holders due to repeated failure to submit required annual reports, and is offering NDA holders the chance to request a hearing on this proposal